ABBVAbbVie

Median target
$280
calls from the last 12 months
Implied return
+6.1%
median target vs. price
Coverage
30 analysts · 34 calls
updated in the last 12 months
Consensus
23/7/0+23 net
Buy / Hold / Sell

Which analysts are behind ABBV's consensus?

See every current rating, price target and the analysts' track records for AbbVie — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 30 analysts with calls on ABBV updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ABBV elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-14InsidersDonoghoe NicholasEVP, CHIEF BUS/STRAT OFFInsider sale32.7K sh @ $250.00$8.2M
2026-05-05CongressJosh GottheimerNJ-NJ05Salesince trade +29.0%, vs market -23.7%$1K–$15K
2026-03-23ExecutiveTrump, Donald JPresidentTransactionAbbVie Inc.$1,001 - $15,000
2026-03-17ExecutiveTrump, Donald JPresidentTransactionAbbVie Inc.$1,001 - $15,000
2026-03-12ExecutiveTrump, Donald JPresidentTransactionABBVIE INC COM$15,001 - $50,000
2026-03-11ExecutiveTrump, Donald JPresidentTransactionAbbVie Inc.$15,001 - $50,000
2026-01-30ExecutiveMody, ArjunDeputy CommissionerSaleAbbVie, Inc. (ABBV)$1,001 - $15,000
2026-01-12ExecutiveTrump, Donald JPresidentTransactionAbbVie Inc.$1,001 - $15,000
2025-12-23ExecutiveTrump, Donald JPresidentSaleABBVIE INC$1,001 - $15,000
2025-12-18CongressJulie JohnsonTX-TX32Salesince trade +21.3%, vs market -8.0%$1K–$15K

More: congressional trades on ABBV · insider activity · executive branch · trending